about
Genome-scale identification of membrane-associated human mRNAs.Gamma-enolase: a well-known tumour marker, with a less-known role in cancerAutologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques.The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung CancerTumor markers in clinical practice: General principles and guidelines.The sweet and sour of serological glycoprotein tumor biomarker quantification.The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma.Tumor marker requests in a general teaching Turkish hospital.Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor MarkersThe use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer.Ultrasensitive Luminescent In Vitro Detection for Tumor Markers Based on Inorganic Lanthanide Nano-Bioprobes.Multiplexed cancer biomarker detection using chip-integrated silicon photonic sensor arrays.Comparison of chemiluminescence enzyme immunoassay based on magnetic microparticles with traditional colorimetric ELISA for the detection of serum α-fetoprotein.Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer.Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
P2860
Q25256725-79C96163-858A-4719-970C-7841F8B452A4Q26781703-CA77AEBB-CBF5-419D-B670-54DBD91CF87CQ30530883-3D93439F-B8BD-44D2-9A6E-906A2F6EFDC2Q33747929-5200A723-9FFF-4CF4-BA84-7CCFB7F37D1AQ33985481-345D9299-E3E8-4BC4-AA87-3861A6FC1793Q34580285-C230139A-2361-4DE9-86D9-49FC3A548BB1Q36191929-1857534B-D9E1-4A22-88A5-3DBD14D21B85Q36266090-1D008D2B-D3F7-47D0-B6D6-59388D72B3A5Q36372283-D994AE9E-0B42-4C13-9FDE-CFB1C48F8E48Q37228450-626FA1A9-6A14-4F2B-AFD0-ADB1E5C30C04Q37404644-83F2F853-2A6E-45F4-B4D2-2874A1BA4EB4Q41504856-5753BF2B-78AB-42D1-9B5E-B309C5D8144FQ50196867-02EB4CC1-247C-4528-AE61-0FF965D7584FQ55436667-EBC3CF7B-64A7-4DDB-9452-F521D24C1300Q58591218-0A9991FD-E10F-437D-8C04-0A3D682445B1
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Practice guidelines for tumor marker use in the clinic.
@ast
Practice guidelines for tumor marker use in the clinic.
@en
Practice guidelines for tumor marker use in the clinic.
@nl
type
label
Practice guidelines for tumor marker use in the clinic.
@ast
Practice guidelines for tumor marker use in the clinic.
@en
Practice guidelines for tumor marker use in the clinic.
@nl
prefLabel
Practice guidelines for tumor marker use in the clinic.
@ast
Practice guidelines for tumor marker use in the clinic.
@en
Practice guidelines for tumor marker use in the clinic.
@nl
P1433
P1476
Practice guidelines for tumor marker use in the clinic
@en
P2093
Catharine Sturgeon
P304
P407
P577
2002-08-01T00:00:00Z